sepsis
Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance
The quality controls are designed to verify the performance of the Luminex Verigene Blood Culture Gram-Positive and Gram-Negative tests.
The COVID-19 pandemic has made the public savvier about diagnostics, but at which point should the involvement of patients in their own testing be limited?
Prenosis Wins $4.8M in NIH Grants to Study Sepsis in Acute Care Settings
The firm will use two Small Business Innovation Research grants to study why patients develop sepsis and how best to treat them using its Immunix AI platform.
Top Five Articles on 360Dx Last Week: Biocartis Reorganizing; CDC's New Training Program; and More
Last week, readers were most interested in a story about layoffs at Biocartis as part of a plan to save €18 million in annual operating expenses.
DiaSorin Gains CE Mark for Sepsis, Severe Infection Assay
The firm's immunodiagnostic assay is intended to aid diagnosis of conditions such as sepsis, septic shock, and severe kidney diseases.